Winner Medical Co Ltd Net Assets
Winner Medical Co Ltd net assets. Based on the latest financial reports, Winner Medical Co Ltd (300888) has net assets worth CN¥12.49 Billion CNY (≈ $1.83 Billion USD) as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥18.97 Billion ≈ $2.78 Billion USD) and total liabilities (CN¥6.48 Billion ≈ $948.26 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore how fast is Winner Medical Co Ltd growing its equity to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥12.49 Billion |
| % of Total Assets | 65.84% |
| Annual Growth Rate | 26.35% |
| 5-Year Change | 15.02% |
| 10-Year Change | 643.51% |
| Growth Volatility | 60.61 |
Net Assets of Winner Medical Co Ltd (2013–2025)
Net assets of Winner Medical Co Ltd from 2013 to 2025. This chart illustrates how Winner Medical Co Ltd's net assets have evolved over time, based on quarterly financial data. See 300888 net asset quality score to measure how much of total assets are equity-financed.
Annual Net Assets for Winner Medical Co Ltd (2013–2025)
The table below shows the annual net assets of Winner Medical Co Ltd from 2013 to 2025. For live market cap and overall valuation, see Winner Medical Co Ltd (300888) market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥12.29 Billion ≈ $1.80 Billion |
+3.51% |
| 2024-12-31 | CN¥11.88 Billion ≈ $1.74 Billion |
-1.94% |
| 2023-12-31 | CN¥12.11 Billion ≈ $1.77 Billion |
-0.72% |
| 2022-12-31 | CN¥12.20 Billion ≈ $1.78 Billion |
+14.14% |
| 2021-12-31 | CN¥10.69 Billion ≈ $1.56 Billion |
+2.68% |
| 2020-12-31 | CN¥10.41 Billion ≈ $1.52 Billion |
+229.01% |
| 2019-12-31 | CN¥3.16 Billion ≈ $462.93 Million |
+18.90% |
| 2018-12-31 | CN¥2.66 Billion ≈ $389.33 Million |
+34.54% |
| 2017-12-31 | CN¥1.98 Billion ≈ $289.38 Million |
+19.61% |
| 2016-12-31 | CN¥1.65 Billion ≈ $241.93 Million |
+26.21% |
| 2015-12-31 | CN¥1.31 Billion ≈ $191.69 Million |
+14.71% |
| 2014-12-31 | CN¥1.14 Billion ≈ $167.10 Million |
+53.80% |
| 2013-12-31 | CN¥742.46 Million ≈ $108.65 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Winner Medical Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 7058.1% over the analyzed period, indicating profitable operations and earnings retention.
Winner Medical Co Ltd Net Assets Breakdown (December 2025)
Winner Medical Co Ltd net assets breakdown by equity component as of December 2025.
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥7.14 Billion | 62.00% |
| Other Components | CN¥4.38 Billion | 38.00% |
| Total Equity | CN¥11.52 Billion | 100.00% |
Winner Medical Co Ltd Competitors by Market Cap
The table below lists competitors of Winner Medical Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Welspun Living Limited
NSE:WELSPUNLIV
|
$2.62 Billion |
|
Hyundai Construction Equipment Co Ltd
KO:267270
|
$2.62 Billion |
|
Liberty Live Holdings, Inc. Series A Liberty Live Group Common Stock
NASDAQ:LLYVA
|
$2.62 Billion |
|
HSBC Holdings PLC
LSE:HSBA
|
$2.62 Billion |
|
Russel Metals Inc.
TO:RUS
|
$2.62 Billion |
|
K+S Aktiengesellschaft
F:SDF1
|
$2.61 Billion |
|
China Petroleum Engineering Corp
SHG:600339
|
$2.61 Billion |
|
Viscofan
MC:VIS
|
$2.61 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Winner Medical Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 11,151,279,644 to 11,516,711,030, a change of 365,431,386 (3.3%).
- Net income of 767,967,462 contributed positively to equity growth.
- Dividend payments of 606,825,040 reduced retained earnings.
- Other comprehensive income decreased equity by 548,402,179.
- Other factors increased equity by 752,691,144.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥767.97 Million | +6.67% |
| Dividends Paid | CN¥606.83 Million | -5.27% |
| Other Comprehensive Income | CN¥-548.40 Million | -4.76% |
| Other Changes | CN¥752.69 Million | +6.54% |
| Total Change | CN¥- | 3.28% |
Book Value vs Market Value Analysis
This analysis compares Winner Medical Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.55x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 15.20x to 1.55x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2013-12-31 | CN¥2.02 | CN¥30.66 | x |
| 2014-12-31 | CN¥3.10 | CN¥30.66 | x |
| 2015-12-31 | CN¥2.54 | CN¥30.66 | x |
| 2016-12-31 | CN¥3.20 | CN¥30.66 | x |
| 2017-12-31 | CN¥3.80 | CN¥30.66 | x |
| 2018-12-31 | CN¥5.09 | CN¥30.66 | x |
| 2019-12-31 | CN¥5.99 | CN¥30.66 | x |
| 2020-12-31 | CN¥19.07 | CN¥30.66 | x |
| 2021-12-31 | CN¥17.90 | CN¥30.66 | x |
| 2022-12-31 | CN¥19.81 | CN¥30.66 | x |
| 2023-12-31 | CN¥19.47 | CN¥30.66 | x |
| 2024-12-31 | CN¥19.08 | CN¥30.66 | x |
| 2025-12-31 | CN¥19.78 | CN¥30.66 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Winner Medical Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 6.67%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 7.01%
- • Asset Turnover: 0.59x
- • Equity Multiplier: 1.60x
- Recent ROE (6.67%) is below the historical average (15.39%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | 11.89% | 6.93% | 1.11x | 1.54x | CN¥13.99 Million |
| 2014 | 11.32% | 8.55% | 1.00x | 1.32x | CN¥15.03 Million |
| 2015 | 16.87% | 12.12% | 1.08x | 1.29x | CN¥89.81 Million |
| 2016 | 24.81% | 16.00% | 1.11x | 1.39x | CN¥244.53 Million |
| 2017 | 21.63% | 12.21% | 1.03x | 1.72x | CN¥229.71 Million |
| 2018 | 15.98% | 11.06% | 0.97x | 1.49x | CN¥158.98 Million |
| 2019 | 17.29% | 11.94% | 1.01x | 1.43x | CN¥230.26 Million |
| 2020 | 36.66% | 30.40% | 0.93x | 1.30x | CN¥2.77 Billion |
| 2021 | 11.61% | 15.42% | 0.61x | 1.24x | CN¥171.83 Million |
| 2022 | 14.09% | 14.54% | 0.62x | 1.56x | CN¥478.76 Million |
| 2023 | 5.03% | 7.09% | 0.48x | 1.48x | CN¥-572.92 Million |
| 2024 | 6.24% | 7.75% | 0.49x | 1.65x | CN¥-419.75 Million |
| 2025 | 6.67% | 7.01% | 0.59x | 1.60x | CN¥-383.70 Million |
Industry Comparison
This section compares Winner Medical Co Ltd's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $1,996,688,898
- Average return on equity (ROE) among peers: 11.74%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Winner Medical Co Ltd (300888) | CN¥12.49 Billion | 11.89% | 0.52x | $2.62 Billion |
| Beijing Centergate Technologies Holding Co Ltd (000931) | $459.59 Million | 18.46% | 1.95x | $412.17 Million |
| Blue Sail Medical Co Ltd (002382) | $9.55 Billion | -5.95% | 0.64x | $816.83 Million |
| Andon Health Co Ltd (002432) | $1.37 Billion | -12.12% | 0.53x | $3.64 Billion |
| Allmed Medical Products Co Ltd Class A (002950) | $2.06 Billion | 15.82% | 0.53x | $782.11 Million |
| Guangzhou Improve Med Instrument (300030) | $592.55 Million | 4.90% | 0.10x | $332.54 Million |
| QITIAN Technology Group Co Ltd (300061) | $64.46 Million | 19.72% | 1.76x | $741.56 Million |
| Shanghai Tofflon Science Tech (300171) | $113.69 Million | 40.44% | 1.35x | $1.49 Billion |
| Truking Technology Ltd (300358) | $2.87 Billion | 6.98% | 1.40x | $927.12 Million |
| Jiangxi Sanxin Medtec Co Ltd (300453) | $1.33 Billion | 15.49% | 0.52x | $724.25 Million |
| Shenyang Xingqi Pharmaceutical Co Ltd (300573) | $1.55 Billion | 13.64% | 0.15x | $1.25 Billion |
About Winner Medical Co Ltd
Winner Medical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of disposable medical products in China and internationally. It operates in two segments, Medical Consumables and Consumer Products. The company offers wound care solutions, including gauzes, bandages, adhesive and film dressings, cotton and non-woven products, basic kits, liquid s… Read more